Fig. 2From: Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United StatesAnnual cases, hospitalizations, and deaths between 2025 and 2033 under varying treatment coverage in three transmission scenarios and three immune durations. The current treatment coverage is 13.7%. The vaccination coverage through the entire period is 49%Back to article page